SUNITINIB MALATE
Active substance: sunitinib malate
CAPSULE · SUNITINIB MALATE 37.5 mg/1
United StatesActive
Marketing holder: Aurobindo Pharma Limited
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- SUNITINIB MALATE · 37.5 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2aef-7ba3-bc0e-428dcfbb0ce8,01a1208c-3fe7-75eb-a6f0-ec6e8c3e33aa,01a1208c-4ccf-772d-8a11-fe1c76f7dc89,01a1208c-8126-72f7-bd2c-e269c26ace96,01a1208c-8f1b-7e56-ada3-cf0182ae93aa;count=36 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 59651-466
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 59651-466 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 59651-466 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 59651-466 · Verified 2026-10-09 · open in source